APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Chronic Urticaria Or Hives Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Chronic Urticaria Or Hives Drug Industry Growth and Trends Forecast to 2032

Report ID 173978090126 December 2025106 pages

Choose your research edition.

Industry ResearchChronic Urticaria Or Hives Drug Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Urticaria Or Hives Drug Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Chronic Urticaria Or Hives Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Urticaria Or Hives Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Urticaria Or Hives Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Chronic Urticaria Or Hives Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Chronic Urticaria Or Hives Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Chronic Urticaria Or Hives Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chronic Urticaria Or Hives Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chronic Urticaria Or Hives Drug include Novartis AG, Merck & Co., Inc., AstraZeneca Plc, Panacea Biotec Limited, Mycenax Biotech Inc., Mabtech Limited, J Uriach Y Compania, S.A., GlaxoSmithKline Plc and Genentech, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Chronic Urticaria Or Hives Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Chronic Urticaria Or Hives Drug market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chronic Urticaria Or Hives Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chronic Urticaria Or Hives Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Chronic Urticaria Or Hives Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Chronic Urticaria Or Hives Drug Market by Company

Novartis AG

Merck & Co., Inc.

AstraZeneca Plc

Panacea Biotec Limited

Mycenax Biotech Inc.

Mabtech Limited

J Uriach Y Compania, S.A.

GlaxoSmithKline Plc

Genentech, Inc.

Faes Farma, SA

ELORAC, Inc.

Biofrontera AG

Chronic Urticaria Or Hives Drug Segment by Type

BF-Derm-1

GDC-0853

GSK-2646264

Bilastine

Others

Chronic Urticaria Or Hives Drug Segment by Application

Clinic

Hospital

Others

Chronic Urticaria Or Hives Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Urticaria Or Hives Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Urticaria Or Hives Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Urticaria Or Hives Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chronic Urticaria Or Hives Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Chronic Urticaria Or Hives Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of BF-Derm-1 Table 2. Major Company of GDC-0853 Table 3. Major Company of GSK-2646264 Table 4. Major Company of Bilastine Table 5. Major Company of Others Table 6. Global Chronic Urticaria Or Hives Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Chronic Urticaria Or Hives Drug Sales by Type (2021-2026) & (W Units) Table 8. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Chronic Urticaria Or Hives Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Chronic Urticaria Or Hives Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Chronic Urticaria Or Hives Drug Price by Type (2021-2026) & (US$/Unit) Table 12. Global Chronic Urticaria Or Hives Drug Sales by Type (2027-2032) & (W Units) Table 13. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Chronic Urticaria Or Hives Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Chronic Urticaria Or Hives Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Chronic Urticaria Or Hives Drug Price by Type (2027-2032) & (US$/Unit) Table 17. North America Chronic Urticaria Or Hives Drug Sales by Type (2021-2026) & (W Units) Table 18. North America Chronic Urticaria Or Hives Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Chronic Urticaria Or Hives Drug Sales by Type (2021-2026) & (W Units) Table 20. Europe Chronic Urticaria Or Hives Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Chronic Urticaria Or Hives Drug Sales by Type (2021-2026) & (W Units) Table 24. Latin America Chronic Urticaria Or Hives Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Chronic Urticaria Or Hives Drug Industry Trends Table 28. Chronic Urticaria Or Hives Drug Industry Drivers Table 29. Chronic Urticaria Or Hives Drug Industry Opportunities and Challenges Table 30. Chronic Urticaria Or Hives Drug Industry Restraints Table 31. Global Chronic Urticaria Or Hives Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Company (2021-2026) Table 33. Global Chronic Urticaria Or Hives Drug Sales by Company (2021-2026) & (W Units) Table 34. Global Chronic Urticaria Or Hives Drug Sales Share by Company (2021-2026) Table 35. Global Chronic Urticaria Or Hives Drug Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Chronic Urticaria Or Hives Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Chronic Urticaria Or Hives Drug Major Company Production Sites and Headquarters Table 38. Global Chronic Urticaria Or Hives Drug Company, Product Type & Application Table 39. Global Chronic Urticaria Or Hives Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Chronic Urticaria Or Hives Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Chronic Urticaria Or Hives Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Chronic Urticaria Or Hives Drug Sales by Region (2021-2026) & (W Units) Table 44. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Chronic Urticaria Or Hives Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Chronic Urticaria Or Hives Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Chronic Urticaria Or Hives Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Chronic Urticaria Or Hives Drug Sales by Region (2027-2032) & (W Units) Table 49. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Chronic Urticaria Or Hives Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Chronic Urticaria Or Hives Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Chronic Urticaria Or Hives Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Chronic Urticaria Or Hives Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Chronic Urticaria Or Hives Drug Sales by Application (2021-2026) & (W Units) Table 55. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Chronic Urticaria Or Hives Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Chronic Urticaria Or Hives Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Chronic Urticaria Or Hives Drug Sales by Application (2027-2032) & (W Units) Table 60. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Chronic Urticaria Or Hives Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Chronic Urticaria Or Hives Drug Price by Application (2027-2032) & (US$/Unit) Table 64. North America Chronic Urticaria Or Hives Drug Sales by Application (2021-2026) & (W Units) Table 65. North America Chronic Urticaria Or Hives Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Chronic Urticaria Or Hives Drug Sales by Application (2021-2026) & (W Units) Table 67. Europe Chronic Urticaria Or Hives Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Chronic Urticaria Or Hives Drug Sales by Application (2021-2026) & (W Units) Table 71. Latin America Chronic Urticaria Or Hives Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Novartis AG Company Information Table 75. Novartis AG Business Overview Table 76. Novartis AG Chronic Urticaria Or Hives Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Novartis AG Chronic Urticaria Or Hives Drug Product Portfolio Table 78. Novartis AG Recent Development Table 79. Merck & Co., Inc. Company Information Table 80. Merck & Co., Inc. Business Overview Table 81. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product Portfolio Table 83. Merck & Co., Inc. Recent Development Table 84. AstraZeneca Plc Company Information Table 85. AstraZeneca Plc Business Overview Table 86. AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Portfolio Table 88. AstraZeneca Plc Recent Development Table 89. Panacea Biotec Limited Company Information Table 90. Panacea Biotec Limited Business Overview Table 91. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Portfolio Table 93. Panacea Biotec Limited Recent Development Table 94. Mycenax Biotech Inc. Company Information Table 95. Mycenax Biotech Inc. Business Overview Table 96. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Portfolio Table 98. Mycenax Biotech Inc. Recent Development Table 99. Mabtech Limited Company Information Table 100. Mabtech Limited Business Overview Table 101. Mabtech Limited Chronic Urticaria Or Hives Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Mabtech Limited Chronic Urticaria Or Hives Drug Product Portfolio Table 103. Mabtech Limited Recent Development Table 104. J Uriach Y Compania, S.A. Company Information Table 105. J Uriach Y Compania, S.A. Business Overview Table 106. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Portfolio Table 108. J Uriach Y Compania, S.A. Recent Development Table 109. GlaxoSmithKline Plc Company Information Table 110. GlaxoSmithKline Plc Business Overview Table 111. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Portfolio Table 113. GlaxoSmithKline Plc Recent Development Table 114. Genentech, Inc. Company Information Table 115. Genentech, Inc. Business Overview Table 116. Genentech, Inc. Chronic Urticaria Or Hives Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Genentech, Inc. Chronic Urticaria Or Hives Drug Product Portfolio Table 118. Genentech, Inc. Recent Development Table 119. Faes Farma, SA Company Information Table 120. Faes Farma, SA Business Overview Table 121. Faes Farma, SA Chronic Urticaria Or Hives Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Faes Farma, SA Chronic Urticaria Or Hives Drug Product Portfolio Table 123. Faes Farma, SA Recent Development Table 124. ELORAC, Inc. Company Information Table 125. ELORAC, Inc. Business Overview Table 126. ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Portfolio Table 128. ELORAC, Inc. Recent Development Table 129. Biofrontera AG Company Information Table 130. Biofrontera AG Business Overview Table 131. Biofrontera AG Chronic Urticaria Or Hives Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Biofrontera AG Chronic Urticaria Or Hives Drug Product Portfolio Table 133. Biofrontera AG Recent Development Table 134. North America Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 135. North America Chronic Urticaria Or Hives Drug Sales by Country (2021-2026) & (W Units) Table 136. North America Chronic Urticaria Or Hives Drug Sales Market Share by Country (2021-2026) Table 137. North America Chronic Urticaria Or Hives Drug Sales Forecast by Country (2027-2032) & (W Units) Table 138. North America Chronic Urticaria Or Hives Drug Sales Market Share Forecast by Country (2027-2032) Table 139. North America Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. North America Chronic Urticaria Or Hives Drug Market Size by Country (2021-2026) & (US$ Million) Table 141. North America Chronic Urticaria Or Hives Drug Market Share by Country (2021-2026) Table 142. North America Chronic Urticaria Or Hives Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. North America Chronic Urticaria Or Hives Drug Market Share Forecast by Country (2027-2032) Table 144. Europe Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 145. Europe Chronic Urticaria Or Hives Drug Sales by Country (2021-2026) & (W Units) Table 146. Europe Chronic Urticaria Or Hives Drug Sales Market Share by Country (2021-2026) Table 147. Europe Chronic Urticaria Or Hives Drug Sales Forecast by Country (2027-2032) & (W Units) Table 148. Europe Chronic Urticaria Or Hives Drug Sales Market Share Forecast by Country (2027-2032) Table 149. Europe Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Europe Chronic Urticaria Or Hives Drug Market Size by Country (2021-2026) & (US$ Million) Table 151. Europe Chronic Urticaria Or Hives Drug Market Share by Country (2021-2026) Table 152. Europe Chronic Urticaria Or Hives Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Europe Chronic Urticaria Or Hives Drug Market Share Forecast by Country (2027-2032) Table 154. Asia-Pacific Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 155. Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Country (2021-2026) & (W Units) Table 156. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Market Share by Country (2021-2026) Table 157. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Forecast by Country (2027-2032) & (W Units) Table 158. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Market Share Forecast by Country (2027-2032) Table 159. Asia-Pacific Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Asia-Pacific Chronic Urticaria Or Hives Drug Market Size by Country (2021-2026) & (US$ Million) Table 161. Asia-Pacific Chronic Urticaria Or Hives Drug Market Share by Country (2021-2026) Table 162. Asia-Pacific Chronic Urticaria Or Hives Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Asia-Pacific Chronic Urticaria Or Hives Drug Market Share Forecast by Country (2027-2032) Table 164. Latin America Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 165. Latin America Chronic Urticaria Or Hives Drug Sales by Country (2021-2026) & (W Units) Table 166. Latin America Chronic Urticaria Or Hives Drug Sales Market Share by Country (2021-2026) Table 167. Latin America Chronic Urticaria Or Hives Drug Sales Forecast by Country (2027-2032) & (W Units) Table 168. Latin America Chronic Urticaria Or Hives Drug Sales Market Share Forecast by Country (2027-2032) Table 169. Latin America Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Latin America Chronic Urticaria Or Hives Drug Market Size by Country (2021-2026) & (US$ Million) Table 171. Latin America Chronic Urticaria Or Hives Drug Market Share by Country (2021-2026) Table 172. Latin America Chronic Urticaria Or Hives Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Latin America Chronic Urticaria Or Hives Drug Market Share Forecast by Country (2027-2032) Table 174. Middle East and Africa Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 175. Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Country (2021-2026) & (W Units) Table 176. Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share by Country (2021-2026) Table 177. Middle East and Africa Chronic Urticaria Or Hives Drug Sales Forecast by Country (2027-2032) & (W Units) Table 178. Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share Forecast by Country (2027-2032) Table 179. Middle East and Africa Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Middle East and Africa Chronic Urticaria Or Hives Drug Market Size by Country (2021-2026) & (US$ Million) Table 181. Middle East and Africa Chronic Urticaria Or Hives Drug Market Share by Country (2021-2026) Table 182. Middle East and Africa Chronic Urticaria Or Hives Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Middle East and Africa Chronic Urticaria Or Hives Drug Market Share Forecast by Country (2027-2032) Table 184. Key Raw Materials Table 185. Raw Materials Key Suppliers Table 186. Chronic Urticaria Or Hives Drug Distributors List Table 187. Chronic Urticaria Or Hives Drug Customers List Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Chronic Urticaria Or Hives Drug Image Figure 2. Global Chronic Urticaria Or Hives Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chronic Urticaria Or Hives Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Chronic Urticaria Or Hives Drug Sales (2021-2032) & (W Units) Figure 5. BF-Derm-1 Image Figure 6. Global BF-Derm-1 Sales YoY Growth (2021-2032) & (W Units) Figure 7. GDC-0853 Image Figure 8. Global GDC-0853 Sales YoY Growth (2021-2032) & (W Units) Figure 9. GSK-2646264 Image Figure 10. Global GSK-2646264 Sales YoY Growth (2021-2032) & (W Units) Figure 11. Bilastine Image Figure 12. Global Bilastine Sales YoY Growth (2021-2032) & (W Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global Chronic Urticaria Or Hives Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Chronic Urticaria Or Hives Drug Market Share by Type 2025 VS 2032 Figure 17. North America Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Chronic Urticaria Or Hives Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Chronic Urticaria Or Hives Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Chronic Urticaria Or Hives Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Chronic Urticaria Or Hives Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 35. Global Chronic Urticaria Or Hives Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Chronic Urticaria Or Hives Drug Market Share by Application 2025 VS 2032 Figure 37. North America Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Chronic Urticaria Or Hives Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. North America Chronic Urticaria Or Hives Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Chronic Urticaria Or Hives Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Chronic Urticaria Or Hives Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Chronic Urticaria Or Hives Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Europe Chronic Urticaria Or Hives Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Chronic Urticaria Or Hives Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Chronic Urticaria Or Hives Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Asia-Pacific Chronic Urticaria Or Hives Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Chronic Urticaria Or Hives Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Chronic Urticaria Or Hives Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Chronic Urticaria Or Hives Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Latin America Chronic Urticaria Or Hives Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Chronic Urticaria Or Hives Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Chronic Urticaria Or Hives Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Middle East and Africa Chronic Urticaria Or Hives Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Chronic Urticaria Or Hives Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Chronic Urticaria Or Hives Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Chronic Urticaria Or Hives Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Chronic Urticaria Or Hives Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • BF-Derm-1
  • GDC-0853
  • GSK-2646264
  • Bilastine
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Novartis AG
  • Merck & Co., Inc.
  • AstraZeneca Plc
  • Panacea Biotec Limited
  • Mycenax Biotech Inc.
  • Mabtech Limited
  • J Uriach Y Compania, S.A.
  • GlaxoSmithKline Plc
  • Genentech, Inc.
  • Faes Farma, SA
  • ELORAC, Inc.
  • Biofrontera AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Chronic Urticaria Or Hives Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Chronic Urticaria Or Hives Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Chronic Urticaria Or Hives Drug Market by Type
  6. 1.3.1 BF-Derm-1
  7. 1.3.2 GDC-0853
  8. 1.3.3 GSK-2646264
  9. 1.3.4 Bilastine
  10. 1.3.5 Others
  11. 1.4 Global Chronic Urticaria Or Hives Drug Market Size by Type
  12. 1.4.1 Global Chronic Urticaria Or Hives Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Chronic Urticaria Or Hives Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Chronic Urticaria Or Hives Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Chronic Urticaria Or Hives Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Chronic Urticaria Or Hives Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Chronic Urticaria Or Hives Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Chronic Urticaria Or Hives Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Chronic Urticaria Or Hives Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Chronic Urticaria Or Hives Drug Industry Trends
  2. 2.2 Chronic Urticaria Or Hives Drug Industry Drivers
  3. 2.3 Chronic Urticaria Or Hives Drug Industry Opportunities and Challenges
  4. 2.4 Chronic Urticaria Or Hives Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Chronic Urticaria Or Hives Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Chronic Urticaria Or Hives Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Chronic Urticaria Or Hives Drug Price (2021-2026)
  4. 3.4 Global Chronic Urticaria Or Hives Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chronic Urticaria Or Hives Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Chronic Urticaria Or Hives Drug Company, Product Type & Application
  7. 3.7 Global Chronic Urticaria Or Hives Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chronic Urticaria Or Hives Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chronic Urticaria Or Hives Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chronic Urticaria Or Hives Drug Tier 1, Tier 2, and Tier 3
4 Chronic Urticaria Or Hives Drug Regional Status and Outlook
  1. 4.1 Global Chronic Urticaria Or Hives Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Chronic Urticaria Or Hives Drug Historic Market Size by Region
  3. 4.2.1 Global Chronic Urticaria Or Hives Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Chronic Urticaria Or Hives Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Chronic Urticaria Or Hives Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Chronic Urticaria Or Hives Drug Forecasted Market Size by Region
  7. 4.3.1 Global Chronic Urticaria Or Hives Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Chronic Urticaria Or Hives Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Chronic Urticaria Or Hives Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Chronic Urticaria Or Hives Drug by Application
  1. 5.1 Chronic Urticaria Or Hives Drug Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Chronic Urticaria Or Hives Drug Market Size by Application
  6. 5.2.1 Global Chronic Urticaria Or Hives Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Chronic Urticaria Or Hives Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Chronic Urticaria Or Hives Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Chronic Urticaria Or Hives Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Chronic Urticaria Or Hives Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Chronic Urticaria Or Hives Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Chronic Urticaria Or Hives Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Chronic Urticaria Or Hives Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Chronic Urticaria Or Hives Drug Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Merck & Co., Inc.
  8. 6.2.1 Merck & Co., Inc. Company Information
  9. 6.2.2 Merck & Co., Inc. Business Overview
  10. 6.2.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product Portfolio
  12. 6.2.5 Merck & Co., Inc. Recent Developments
  13. 6.3 AstraZeneca Plc
  14. 6.3.1 AstraZeneca Plc Company Information
  15. 6.3.2 AstraZeneca Plc Business Overview
  16. 6.3.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Portfolio
  18. 6.3.5 AstraZeneca Plc Recent Developments
  19. 6.4 Panacea Biotec Limited
  20. 6.4.1 Panacea Biotec Limited Company Information
  21. 6.4.2 Panacea Biotec Limited Business Overview
  22. 6.4.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Portfolio
  24. 6.4.5 Panacea Biotec Limited Recent Developments
  25. 6.5 Mycenax Biotech Inc.
  26. 6.5.1 Mycenax Biotech Inc. Company Information
  27. 6.5.2 Mycenax Biotech Inc. Business Overview
  28. 6.5.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Portfolio
  30. 6.5.5 Mycenax Biotech Inc. Recent Developments
  31. 6.6 Mabtech Limited
  32. 6.6.1 Mabtech Limited Company Information
  33. 6.6.2 Mabtech Limited Business Overview
  34. 6.6.3 Mabtech Limited Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mabtech Limited Chronic Urticaria Or Hives Drug Product Portfolio
  36. 6.6.5 Mabtech Limited Recent Developments
  37. 6.7 J Uriach Y Compania, S.A.
  38. 6.7.1 J Uriach Y Compania, S.A. Company Information
  39. 6.7.2 J Uriach Y Compania, S.A. Business Overview
  40. 6.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Portfolio
  42. 6.7.5 J Uriach Y Compania, S.A. Recent Developments
  43. 6.8 GlaxoSmithKline Plc
  44. 6.8.1 GlaxoSmithKline Plc Company Information
  45. 6.8.2 GlaxoSmithKline Plc Business Overview
  46. 6.8.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Portfolio
  48. 6.8.5 GlaxoSmithKline Plc Recent Developments
  49. 6.9 Genentech, Inc.
  50. 6.9.1 Genentech, Inc. Company Information
  51. 6.9.2 Genentech, Inc. Business Overview
  52. 6.9.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Genentech, Inc. Chronic Urticaria Or Hives Drug Product Portfolio
  54. 6.9.5 Genentech, Inc. Recent Developments
  55. 6.10 Faes Farma, SA
  56. 6.10.1 Faes Farma, SA Company Information
  57. 6.10.2 Faes Farma, SA Business Overview
  58. 6.10.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Faes Farma, SA Chronic Urticaria Or Hives Drug Product Portfolio
  60. 6.10.5 Faes Farma, SA Recent Developments
  61. 6.11 ELORAC, Inc.
  62. 6.11.1 ELORAC, Inc. Company Information
  63. 6.11.2 ELORAC, Inc. Business Overview
  64. 6.11.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Portfolio
  66. 6.11.5 ELORAC, Inc. Recent Developments
  67. 6.12 Biofrontera AG
  68. 6.12.1 Biofrontera AG Company Information
  69. 6.12.2 Biofrontera AG Business Overview
  70. 6.12.3 Biofrontera AG Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Biofrontera AG Chronic Urticaria Or Hives Drug Product Portfolio
  72. 6.12.5 Biofrontera AG Recent Developments
7 North America by Country
  1. 7.1 North America Chronic Urticaria Or Hives Drug Sales by Country
  2. 7.1.1 North America Chronic Urticaria Or Hives Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Chronic Urticaria Or Hives Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Chronic Urticaria Or Hives Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Chronic Urticaria Or Hives Drug Market Size by Country
  6. 7.2.1 North America Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Chronic Urticaria Or Hives Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Chronic Urticaria Or Hives Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Chronic Urticaria Or Hives Drug Sales by Country
  2. 8.1.1 Europe Chronic Urticaria Or Hives Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Chronic Urticaria Or Hives Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Chronic Urticaria Or Hives Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Chronic Urticaria Or Hives Drug Market Size by Country
  6. 8.2.1 Europe Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Chronic Urticaria Or Hives Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Chronic Urticaria Or Hives Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Country
  2. 9.1.1 Asia-Pacific Chronic Urticaria Or Hives Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Chronic Urticaria Or Hives Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Chronic Urticaria Or Hives Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Chronic Urticaria Or Hives Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Chronic Urticaria Or Hives Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Chronic Urticaria Or Hives Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Chronic Urticaria Or Hives Drug Sales by Country
  2. 10.1.1 South America Chronic Urticaria Or Hives Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Chronic Urticaria Or Hives Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Chronic Urticaria Or Hives Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Chronic Urticaria Or Hives Drug Market Size by Country
  6. 10.2.1 South America Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Chronic Urticaria Or Hives Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Chronic Urticaria Or Hives Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Country
  2. 11.1.1 Middle East and Africa Chronic Urticaria Or Hives Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Chronic Urticaria Or Hives Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Chronic Urticaria Or Hives Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Chronic Urticaria Or Hives Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Chronic Urticaria Or Hives Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Chronic Urticaria Or Hives Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Chronic Urticaria Or Hives Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Chronic Urticaria Or Hives Drug Value Chain Analysis
  2. 12.1.1 Chronic Urticaria Or Hives Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Chronic Urticaria Or Hives Drug Production Mode & Process
  7. 12.2 Chronic Urticaria Or Hives Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Chronic Urticaria Or Hives Drug Distributors
  10. 12.2.3 Chronic Urticaria Or Hives Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst